Increased serum remnant lipoproteins in patients with apolipoprotein E7 (apo E(Suita))

Atherosclerosis

Volumn 131, Issue 1, 1997, Pages 49-58

  Yanagi, Koji ^a   Yamashita, Shizuya ^a   Hiraoka, Hisatoyo ^a   Ishigami, Masato ^a   Kihara, Shinji ^a   Hirano, Ken Ichi ^a   Sakai, Naohiko ^a   Nozaki, Shuichi ^a   Funahashi, Tohru ^a   Kameda Takemura, Kaoru ^a   Kubo, Masaharu ^a   Tokunaga, Katsuto ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Apolipoprotein E7 (apo E7); Intermediate density lipoprotein (IDL); Midband; Remnant lipoprotein; Type III hyperlipoproteinemia; Very low density lipoprotein (VLDL)

Indexed keywords

ADULT; AGING; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DISEASE ASSOCIATION; GLUCOSE METABOLISM; HUMAN; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA; ISCHEMIC HEART DISEASE; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; MUTATION; OBESITY; PRIORITY JOURNAL;

ADULT; AGED; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, VLDL; DNA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOPROTEINS; HETEROZYGOTE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 17944387555     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06068-6     Document Type: Article

References (53)

1. Mahley RW, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta 1983;737:197.
2. Mahley RW, Innerarity TL, Weisgraber KH, Rall SC Jr, Hui DY, Lalazar A, Boyles JK, Taylor JM, Levy-Wilson B. Cellular and molecular biology of lipoprotein metabolism: characterization of lipoprotein receptor-ligand interaction. Cold Spring Harbor, Symp Quant Biol 1986;51:821.
3. Gregg RE, Brewer HB Jr. The role of apolipoprotein E and lipoprotein receptors in modulating the in vivo metabolism of apolipoprotein B-containing lipoproteins in humans. Clin Chem 1988;34:B28.
4. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1.
5. Zannis VI. Molecular biology of human apolipoproteins B and E and associated diseases of lipoprotein metabolism. Adv Lipid Res 1989;23:1.
6. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1989;240:622.
7. Rail SC Jr, Weisgraber KH, Mahley RW. Human apolipoprotein E: the complete amino acid sequence. J Biol Chem 1982;257:4171.
8. Paik Y, Chang DJ, Reardon CA, Davies GE, Mahley RW, Taylor JM. Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci USA 1985;82:3445.
9. Bouthillier D, Sing CF, Davignon J. Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings. J Lipid Res 1983;24:1060.
10. Havekes LM, de Knijff P, Beisiegel U, Havinga J, Smit M, Klasen E. A rapid micro-method for apolipoprotein E phenotyping directly in serum. J Lipid Res 1987;28:455.
11. Weisgraber KH, Rall SC Jr, Mahley RW. Human E apolipoprotein heterogeneity: Cysteine-arginine interchanges in the amino acid sequence of the apo E isoforms. J Biol Chem 1981;256:9077.
12. Rall SC Jr, Weisgraber KH, Innerarity TL, Mahley RW, Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci USA 1982;79:4696.
13. 146 → Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype. J Clin Invest, 1983;72:1288.
14. Bethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia. J Clin Endocrinol Metab. 1983;57:969.
15. McLean JW, Elshourbagy NA, Chang DJ, Mahley RW, Taylor JM. Human apolipoprotein E mRNA: cDNA cloning and nucleotide sequencing of a new variant. J Biol Chem 1984;259:6498.
16. Weisgraber KH, Rall SC Jr, Innerarity TL, Mahley RW. A novel electrophoretic variant of human apolipoprotein E: identification and characterization of apolipoprotein El. J Clin Invest 1984;73:1024
17. Havekes L, de Wit E, Gevers Leuven J, Klasen E, Utermann G, Weber W, Beisiegel U. Apolipoprotein E3-Leiden, a new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia. Hum Genet 1986;73:157.
18. Arg → Ser): new variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. J Clin Invest 1987;80:483.
19. Tajima S, Yamamura T, Yamamoto A. Analysis of apolipoprotein E5 gene from a patient with hyperlipoproteinemia. J Biochem 1988;104:48
20. Suita) gene from a patient with hyperlipoproteinemia. J Biochem 1989;105:249.
21. Leiden allele results from a partial gene duplication in exon four, Biochim Biophys Res Commun 1989;165:851.
22. Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121-127. J Biol Chem 1989;264:21 205.
23. Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia. Biochim Biophys Acta 1989;1005:239.
24. Rall SC Jr, Newhouse YM, Clarke HRG, Weisgraber KH, McCarthy BJ, Mahley RW, Bersot TP. Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3: structure and genetics of an apolipoprotein E3 variant. J Clin Invest 1983;83:1095.
25. 146 → Gln) variant results in a dominant mode of inheritance. J Lipid Res 1990;31:45.
26. Dunedin (228 Arg → Cys): an apolipoprotein E2 variant with normal receptor-binding activity. J Lipid Res 1990;31:535.
27. Leiden in an extended multigeneration pedigree. J Clin Invest 1991;88:643
28. Mailly F, Xu CF, Xhignesse M, Lussier-Cacan S, Talmud PJ, Davignon J, Humphries SE, Nestruck AC. Characterization of a new apolipoprotein E5 variant detected in two French-Canadian subjects. J Lipid Res 1991;32:613.
29. 145 → Cys): homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia. J Biol Chem 1991;266:10479.
30. Brewer HB Jr, Zech LA, Gregg RE, Schwartz D, Schaefer EJ. Type III hyperlipoproteinemia: Diagnosis molecular defects pathology and treatment. Ann Intern Med 1983;98:623.
31. Mahley RW, Rall SC Jr. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: The Metabolic and Molecular Bases of Inherited Disease, 7th Ed. New York: McGraw-Hill 1995:1953.
32. Utermann GR, Vogelberg KH, Steinmetz A, Schoenborn W, Pruin N, Jaeschke M, Hees M, Canzler H. Polymorphism of apolipoprotein E: II genetics of hyperlipoproteinemia type III. Clin Genet 1979;15:37.
33. Breslow J, Zannis VI, SanGiacomo TR, Third JLHC, Tracy T, Glueck CJ. Studies of familial type III hypercholesterolemia using as a genetic marker the apo E2/2. J Lipid Res 1982;23:1224.
34. Weisgraber KH, Innerarity TL, Mahley RW. Abnormal lipoprotein receptor-binding of the human E apolipoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 1982;257:2518.
35. Brown MS, Goldstein JL, Fredrickson DS. Familial type III hyperlipoproteinemia. In: The Metabolic Basis of Inherited Disease, 5th edn. New York: McGraw-Hill 1986:655.
36. Horie Y, Fazio S, Westerlund JR, Weisgraber KH, Rall SC Jr. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia. J Biol Chem 1992;267:1962.
37. Leiden gene exhibit hyperlipoproteinemia. J Biol Chem 1993;268:10 540.
38. 145 → Cys) is associated with incomplete dominance of type III hyperlipoproteinemia. J Biol Chem 1992:267;13 642.
39. Yamamura T, Yamamoto A, Sumiyoshi T, Hiramori K, Nishioeda Y, Nambu S. New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia. J Clin Invest 1984;74:1229.
40. Yamamura T, Dong LM, Yamamoto A. Apolipoprotein E polymorphism and coronary heart disease. Chin Med J Engl 1992;105:738.
41. Utermann G, Jaeschke M, Menzel J. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins. FEBS Lett 1975;56:352
42. Burstein M, Scholnick HR. Lipoprotein-polyanion-metal interactions. Adv Lipid Res 1973;11:67.
43. Goto Y, Akanuma Y, Harano Y, Hata Y, Itakura H, Kajiyama G, Kawade M, Koga S, Kuzuya F, Maruhama Y, Matsuzawa Y, Murai A, Murase T, Naito C, Nakai T, Noma A, Saitoh Y, Sasaki J, Takeuchi N, Tamachi H, Uzawa H, Yamamoto A, Yamazaki S, Yasugi T, Yukawa S. Determination by the SRID method of normal values of serum apolipoproteins (A-I A-II B C-II C-III and E) in normolipidemic healthy Japanese subjects. J Clin Biochem Nutr 1986;1:73.
44. Narayan KA, Creinin HL, Kummerow FA. Disc electrophoresis of rat plasma lipoproteins. J Lipid Res 1966;7:150.
45. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345
46. Albers JJ, Tollefson JH, Chen CH, Steinmetz A. Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis 1984;4:49.
47. Hofker MH, Wapenaar MC, Goor N, Bakker E, van Ommen G-JB, Pearson PL. Isolation of probes detecting restriction fragment length polymorphisms from X chromosome-specific libraries: potential use for diagnosis of Duchenne muscular dystrophy. Hum Genet 1985;70:148.
48. 245 → Lys) variants in western Japan. Clin Genet 1995;48:93.
49. Emi M, Wu LL, Robertson MA, Myers RL, Hegele RA, Williams RR, White R, Lalouel J-M. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988;3:373.
50. Tall A, Granot E, Brocia R, Tabas I, Hesler C, Williams K, Denke M. Accelerated transfer of cholesteryl esters in dyslipidemic plasma, role of cholesteryl ester transfer protein. J Clin Invest 1987;79:1217.
51. Sing CF, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985;37:268.
52. Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brewer HB Jr. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 1986;70:815.
53. Ueyama Y, Nozaki S, Yanagi K, Hiraoka H, Nakagawa T, Sakai N, Jiao S, Yamashita S. Matsuzawa Y. Familial hypercholesterolemia-like syndrome with apolipoprotein E7 associated with marked achilles tendon xanthomas and coronary artery disease: report of two cases. J Intern Med 1994;235:169.